Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune Diseases
Authors:
- Michael J. MihatschMMMichael J. Mihatsch
Open Access
- 18 June 1992
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (25) , 1654-1660
Abstract
Cyclosporine is an immunosuppressive drug that is used to treat patients with autoimmune disease as well as patients who have received allografts. The drug can cause renal damage, but the incidence of and risk factors for nephropathy in patients treated with cyclosporine for autoimmune or inflammatory diseases are not known.Keywords
This publication has 20 references indexed in Scilit:
- Kidney biopsies in control or cyclosporin Atreated psoriatic patients.British Journal of Dermatology, 1990
- Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial GroupDiabetes, 1988
- CHRONIC INJURY OF HUMAN RENAL MICROVESSELS WITH LOW-DOSE CYCLOSPORINE THERAPYTransplantation, 1988
- Factors Associated with Early Remission of Type I Diabetes in Children Treated with CyclosporineNew England Journal of Medicine, 1988
- Cyclosporin-associated nephropathy in patients with autoimmune diseasesJournal of Molecular Medicine, 1988
- Combined steroid-cyclosporin treatment of chronic autoimmune diseasesJournal of Molecular Medicine, 1987
- Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporineArchives of internal medicine (1960), 1986
- Renal Histopathologic Alterations in Patients Treated with Cyclosporine for UveitisNew England Journal of Medicine, 1986
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- A Radioimmunoassay to Measure Cyclosporin a in Plasma and Serum SamplesJournal of Immunoassay, 1981